YCC Member Center

Why Become a Member? 

Yale Cancer Center is one of only 47 Comprehensive Cancer Centers nationwide designated by the National Cancer Institute. Throughout the fight against cancer, Yale has been at the forefront of understanding the mechanisms of cancer biology and in developing effective therapies for cancer treatment. Yale Cancer Center unites the membership to advance cancer research, prevention, and patient care, as well as community outreach and education by harnessing the resources of the Yale School of Medicine and Smilow Cancer Hospital. (Download Application)


Benefits of Membership

•  Use of the following Shared Resources: 

         Biostatistics and Bioinformatics  

         Cesium Irradiator  

         Clinical Research Services  

         Flow Cytometry  

         Pathology Tissue Services  

         Rapid Case Ascertainment  

         Yale Center for Genome Analysis  

         Yale Center for Molecular Discovery 

•   Eligibility to compete for Cancer Center Support Grant Developmental, 
    Supplemental, Pilot and Philanthropic funding 
•   Eligibility for allocation of YCC space 
•   Enhanced opportunities to develop collaborative research efforts 
•   Facilitated access to clinical populations 
•   YCC publications and announcements of grants, awards, and YCC-supported lectures 
    and seminars 
•   YCC events such as the Annual Retreat, Conclave, and Research Program Retreats

Member Expectations

While YCC Membership has many valuable privileges, there are also important obligations. These include: 
•   Acknowledge membership and YCC support in publications, abstracts, posters, and presentations. This includes acknowledging via My NCBI the CCSG/P30 grant (P30 CA016359-34, PI: Schulam, Peter) for any publications that came from data using any of the YCC-supported Shared Resources and Cores (Please read “Managing Compliance to the NIH Public Access Policy” for more information.) 
•   Submit in a timely and accurate manner, annual and special requests for updates on Research Progress, Other Support, Publications, Curriculum Vitae, and Biosketches. 
•   Participation in the YCC community, including attendance of  Research Program or Disease Team meetings, retreats, symposia, panels, committees, and YCC Grand Rounds. 

 [Full list of expectations here]

Membership Categories and Criteria

There are three types of YCC Membership, Full, Clinical, and Research. Full Members are eligible to apply for Pilot funding, whereas Clinical and Research Members must submit with a Full Member as co-PI.

Full Membership
Full members have an independent Yale faculty appointment, contribute to the peer-reviewed cancer literature, and also have one of the following: 1) Obtained extramural cancer-relevant peer-reviewed grant support as a PI or Co-PI within the past 3 years; 2) Served as investigator or co-investigator on at least one YCC interventional (therapeutic or non-therapeutic) cancer clinical trial within the past 2 years; or 3) Provide specialized medical, scientific, or administrative expertise to the overall research mission of YCC.

Junior faculty members are eligible to apply for Full Membership if they are planning to conduct cancer research and they apply at the time of Yale appointment with the understanding that these members will meet the eligibility requirements within 3 years of receiving membership. [Full eligibility]

Clinical and Research Membership
Clinical and Research Members are individuals who do not meet the criteria for Full Membership, but who meaningfully contribute to activities of YCC. Clinical Members typically hold a clinical appointment and actively treat patients while Research Members are usually engaged in relevant basic or population science research in cancer. They must be affiliated with the Yale School of Medicine, provide substantive clinical, scientific, administrative, basic, or population expertise to the overall research mission of YCC, and optionally one of the following: 1) Contribute to the peer-reviewed cancer literature; 2) Participate on an extramural cancer-relevant peer-reviewed grant; 3) Contribute to YCC interventional (therapeutic or non-therapeutic) cancer clinical trials.

Research Programs

Yale Cancer Center member candidates select from the following seven thematic Research Programs (RPs) when applying for membership after determining which research program will best support their cancer research efforts. Each RP is led by two Program Leaders (PLs), usually one focused on the basic science aspects of the RP, and the other representing the clinical aspects.


Cancer Immunology (CI)
Co-Leaders:
Lieping Chen, MD, PhD - basic
Madhav Dhodapkar, MBBS - clinical

Cancer Prevention and Control (CPC)
Co-Leaders:
Melinda Irwin, PhD, MPH
Xiaomei Ma, PhD

Developmental Therapeutics (DT)
Co-Leaders:
Karen Anderson, PhD - basic
Barbara Burtness, MD - clinical 

Genomics, Genetics and Epigenetics (GGE) 
Co-Leaders: 
Marcus Bosenberg, PhD - basic 
Lajos Pusztai, MD, PhD - clinical 


Radiobiology and Radiotherapy (RR)
Co-Leaders:
Peter Glazer, MD, PhD - clinical
Joann Sweasy, PhD - basic

Signal Transduction Research Program (ST)
Co-Leaders:
Daniel Petrylak, MD - clinical
David Stern, PhD - basic 

Virus and Other Infection-associated Cancers (VOIC)
Co-Leaders: 
Walther Mothes, PhD - basic 
Wendell Yarbrough, MD - clinical 

Applying for Membership

Each applicant must complete and return the following materials to Christina Dreyfus. Please contact or call with any questions, (203) 737-8375. 

•  Signed application [Download here
•  Updated curriculum vitae